Status:

ACTIVE_NOT_RECRUITING

Observational Study in Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder

Lead Sponsor:

Loulou Foundation

Conditions:

Cyclin-Dependent Kinase-Like 5 Deficiency Disorder

Eligibility:

All Genders

Up to 55 years

Brief Summary

Observational, noninterventional, 3-year study to examine the presence of detectable differences in neurocognitive, developmental, motor, neurophysiologic, and quality of life measures over time in pa...

Detailed Description

This is an observational study to examine the presence of detectable differences in neurocognitive, developmental, motor, neurophysiologic, and quality of life measures over time in approximately up t...

Eligibility Criteria

Inclusion

  • Documented diagnosis of Cyclin-dependent Kinase-like 5 (CDKL5) deficiency disorder with pathogenic or likely pathogenic of CDKL5 variants
  • Ages newborn to 55 years old
  • Parent/Caregiver who is willing and capable of providing written informed consent
  • Parent/caregiver lives with or has daily contact with study participant and able to provide consistent information across the study

Exclusion

  • Any clinically significant neurocognitive deficit not attributable to Cyclin-dependent Kinase-like 5 (CDKL5) deficiency disorder or a secondary cause that may, in the opinion of the investigator, confound interpretation of study results (e.g., extreme prematurity, other genetic variants, unclassified CDKL5 variant, abnormal brain imaging, imaging and/or injury not otherwise attributable to CDD).
  • Any condition that, in the opinion of the investigator, would put the patient at undue risk or make it unsafe for the patient to participate
  • Any condition which would make the individual or the caregiver, in the opinion of the investigator, unsuitable for the study

Key Trial Info

Start Date :

September 30 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 20 2027

Estimated Enrollment :

112 Patients enrolled

Trial Details

Trial ID

NCT05373719

Start Date

September 30 2022

End Date

January 20 2027

Last Update

March 10 2025

Active Locations (23)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (23 locations)

1

UCLA Mattel Children's Hospital

Los Angeles, California, United States, 90095

2

Children's Hospital Colorado

Aurora, Colorado, United States, 80045

3

Center for Rare Neurological Diseases

Norcross, Georgia, United States, 30093

4

Boston Children's Hospital

Boston, Massachusetts, United States, 02115